120 related articles for article (PubMed ID: 37534882)
21. Apocrine Metaplasia Found at MR Biopsy: Is There Something to be Learned?
Gao Y; Dialani V; DeBenedectis C; Johnson N; Brachtel E; Slanetz P
Breast J; 2017 Jul; 23(4):429-435. PubMed ID: 28079289
[TBL] [Abstract][Full Text] [Related]
22. Can enhancement types on preoperative MRI reflect prognostic factors and surgical outcomes in invasive breast cancer?
Koh J; Park AY; Ko KH; Jung HK
Eur Radiol; 2019 Dec; 29(12):7000-7008. PubMed ID: 31187220
[TBL] [Abstract][Full Text] [Related]
23. Using Machine Learning Methods to Assess Lymphovascular Invasion and Survival in Breast Cancer: Performance of Combining Preoperative Clinical and MRI Characteristics.
Xu Z; Xie Y; Wu L; Chen M; Shi Z; Cui Y; Han C; Lin H; Liu Y; Li P; Chen X; Ding Y; Liu Z
J Magn Reson Imaging; 2023 Nov; 58(5):1580-1589. PubMed ID: 36797654
[TBL] [Abstract][Full Text] [Related]
24. Correlation between dynamic contrast-enhanced MRI characteristics and apparent diffusion coefficient with Ki-67-positive expression in non-mass enhancement of breast cancer.
Nie T; Feng M; Yang K; Guo X; Yuan Z; Zhang Z; Yan G
Sci Rep; 2023 Dec; 13(1):21451. PubMed ID: 38052920
[TBL] [Abstract][Full Text] [Related]
25. Grading system to categorize breast MRI using BI-RADS 5th edition: a statistical study of non-mass enhancement descriptors in terms of probability of malignancy.
Asada T; Yamada T; Kanemaki Y; Fujiwara K; Okamoto S; Nakajima Y
Jpn J Radiol; 2018 Mar; 36(3):200-208. PubMed ID: 29285740
[TBL] [Abstract][Full Text] [Related]
26. Histopathologic Correlates of Nonmass Enhancement Detected by Breast Magnetic Resonance Imaging.
Torous VF; Resteghini NA; Phillips J; Dialani V; Slanetz PJ; Schnitt SJ; Baker GM
Arch Pathol Lab Med; 2021 Oct; 145(10):1264-1269. PubMed ID: 33450753
[TBL] [Abstract][Full Text] [Related]
27. Non-mass enhancement breast lesions: MRI findings and associations with malignancy.
Liu G; Li Y; Chen SL; Chen Q
Ann Transl Med; 2022 Mar; 10(6):357. PubMed ID: 35433999
[TBL] [Abstract][Full Text] [Related]
28. Magnetic resonance imaging features for differentiating breast papilloma with high-risk or malignant lesions from benign papilloma: a retrospective study on 158 patients.
Wang LJ; Wu P; Li XX; Luo R; Wang DB; Guan WB
World J Surg Oncol; 2018 Dec; 16(1):234. PubMed ID: 30558621
[TBL] [Abstract][Full Text] [Related]
29. Contrasts Between Diffusion-Weighted Imaging and Dynamic Contrast-Enhanced MR in Diagnosing Malignancies of Breast Nonmass Enhancement Lesions Based on Morphologic Assessment.
Li Y; Chen J; Yang Z; Fan C; Qin Y; Tang C; Yin T; Ai T; Xia L
J Magn Reson Imaging; 2023 Sep; 58(3):963-974. PubMed ID: 36738118
[TBL] [Abstract][Full Text] [Related]
30. Breast Cancer Growth on Serial MRI: Volume Doubling Time Based on 3-Dimensional Tumor Volume Assessment.
Wang L; Luo R; Chen Y; Liu H; Guan W; Li R; Zhang Z; Duan S; Wang D
J Magn Reson Imaging; 2023 Oct; 58(4):1303-1313. PubMed ID: 36876593
[TBL] [Abstract][Full Text] [Related]
31. Comparison of conventional DCE-MRI and a novel golden-angle radial multicoil compressed sensing method for the evaluation of breast lesion conspicuity.
Heacock L; Gao Y; Heller SL; Melsaether AN; Babb JS; Block TK; Otazo R; Kim SG; Moy L
J Magn Reson Imaging; 2017 Jun; 45(6):1746-1752. PubMed ID: 27859874
[TBL] [Abstract][Full Text] [Related]
32. Apparent diffusion coefficient values may help predict which MRI-detected high-risk breast lesions will upgrade at surgical excision.
Cheeney S; Rahbar H; Dontchos BN; Javid SH; Rendi MH; Partridge SC
J Magn Reson Imaging; 2017 Oct; 46(4):1028-1036. PubMed ID: 28181343
[TBL] [Abstract][Full Text] [Related]
33. Descriptors of Malignant Non-mass Enhancement of Breast MRI: Their Correlation to the Presence of Invasion.
Machida Y; Shimauchi A; Tozaki M; Kuroki Y; Yoshida T; Fukuma E
Acad Radiol; 2016 Jun; 23(6):687-95. PubMed ID: 26976623
[TBL] [Abstract][Full Text] [Related]
34. Additive value of texture analysis based on breast MRI for distinguishing between benign and malignant non-mass enhancement in premenopausal women.
Tan Y; Mai H; Huang Z; Zhang L; Li C; Wu S; Huang H; Tang W; Liu Y; Jiang K
BMC Med Imaging; 2021 Mar; 21(1):48. PubMed ID: 33706695
[TBL] [Abstract][Full Text] [Related]
35. Nonmass Enhancement Breast Lesions: Diagnostic Performance of Kinetic Assessment on Ultrafast and Standard Dynamic Contrast-Enhanced MRI in Comparison With Morphologic Evaluation.
Mori N; Sheth D; Abe H
AJR Am J Roentgenol; 2020 Aug; 215(2):511-518. PubMed ID: 32452698
[No Abstract] [Full Text] [Related]
36. Breast imaging reporting and data system (BI-RADS) lexicon for breast MRI: interobserver variability in the description and assignment of BI-RADS category.
El Khoury M; Lalonde L; David J; Labelle M; Mesurolle B; Trop I
Eur J Radiol; 2015 Jan; 84(1):71-76. PubMed ID: 25454100
[TBL] [Abstract][Full Text] [Related]
37. Diagnostic performance of initial enhancement analysis using ultra-fast dynamic contrast-enhanced MRI for breast lesions.
Goto M; Sakai K; Yokota H; Kiba M; Yoshida M; Imai H; Weiland E; Yokota I; Yamada K
Eur Radiol; 2019 Mar; 29(3):1164-1174. PubMed ID: 30088064
[TBL] [Abstract][Full Text] [Related]
38. Patterns of malignant non-mass enhancement on 3-T breast MRI help predict invasiveness: using the BI-RADS lexicon fifth edition.
Lee SM; Nam KJ; Choo KS; Kim JY; Jeong DW; Kim HY; Kim JY
Acta Radiol; 2018 Nov; 59(11):1292-1299. PubMed ID: 29758996
[TBL] [Abstract][Full Text] [Related]
39. BI-RADS MRI enhancement characteristics of ductal carcinoma in situ.
Rosen EL; Smith-Foley SA; DeMartini WB; Eby PR; Peacock S; Lehman CD
Breast J; 2007; 13(6):545-50. PubMed ID: 17983393
[TBL] [Abstract][Full Text] [Related]
40. MRI prediction of neoadjuvant chemotherapy response is equivalent in patients with or without mammographic calcifications: a step towards adapting surgical approach?
Sella T; Simor B; Adler-Levy Y; Maly B; Kadouri L; Carmon E
Eur Radiol; 2023 Oct; 33(10):7168-7177. PubMed ID: 37086288
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
